Clinicians Debate Who Should Deliver Psychedelic Medicine

1 source1 article First seen 22 hours ago Updated 22 hours ago Australia Truth score 38

Save Like Comments Compare coverage

Summary

Regulators in Australia have updated psychedelic medicine guidelines, but disagreements persist about who can and can’t lead therapy sessions. Medscape News Australia

Description from Medscape.

Who is covering this

Medscape Center Factuality: Mostly factual US 22 hours ago
Clinicians Debate Who Should Deliver Psychedelic Medicine
Regulators in Australia have updated psychedelic medicine guidelines, but disagreements persist about who can and can’t lead therapy sessions. Medscape News Australia

Comments

Comments need JavaScript.

Truth score

38/100Weakly supported

Independent outlets: 1
Source reliability: 65/100
Sides of the spectrum covering it: 1/3
Propaganda risk: 0/100

How well the story is corroborated by independent, reliable outlets across the spectrum. Not a fact-check of each claim. How the truth score works

Coverage by lean

Centre 100%100%

Left: 0
Centre: 1
Right: 0
Not rated: 0

How lean is counted

Source quality

Average reliability: 65/100 (Mostly factual)
Low-credibility outlets: 0%
State media: 0%
Opinion pieces: 0%

Where ratings come from

Where the coverage comes from

United States1

In this story

Medscape News Australia

Filter the stories

Sources Ratings and details

Clinicians Debate Who Should Deliver Psychedelic Medicine

Summary

Who is covering this

Comments

Summary

Who is covering this

Comments

Related stories

Proposed Health Insurance Rebate Reduction Fuels Debate

As Dementia Deaths Rise, Is Australia’s Health System Ready?